Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
Direct-Acting Cholinergic Agonists: Pharmacokinetics01:31

Direct-Acting Cholinergic Agonists: Pharmacokinetics

Direct-acting cholinergic agonists, such as synthetic choline esters and naturally occurring alkaloids, exert their effects by enhancing the actions of acetylcholine and stimulating the parasympathetic nervous system. Synthetic choline esters share structural similarities with acetylcholine. For example, they have a positively charged quaternary ammonium or onium group, contributing to their hydrophilic characteristics. As a result, they are poorly absorbed in the body through oral...
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship01:22

Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...
Cholinergic Antagonists: Chemistry and Structure-Activity Relationship01:29

Cholinergic Antagonists: Chemistry and Structure-Activity Relationship

Cholinergic antagonists bind to cholinergic receptors and limit the effects of acetylcholine and other cholinergic agonists. Based on the specific cholinergic receptor affinity, these antagonists are classified as muscarinic or nicotinic. Anticholinergics interrupt parasympathetic innervations while sympathetic innervations remain uninterrupted. Muscarinic antagonists are also called 'muscarinic antagonists', 'antimuscarinics', or 'parasympatholytics'. Nicotinic antagonists are called...
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship01:29

Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention01:05

Bioavailability Enhancement: Drug Stability Enhancement and GI Retention

Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of a Tacrine Analogue on Behavioral and Biochemical Parameters in Drosophila melanogaster.

Chemistry & biodiversity·2026
Same author

Neurotechnology-enabled closed-loop optogenetics for modulating autoimmune glial responses in experimental ADEM.

Annals of medicine and surgery (2012)·2026
Same author

Synthesis and structure-activity relationships of indole-3-butyric acid-based hydrazones: predicting their antibacterial and antioxidant potential through integrated experimental, molecular docking and DFT studies.

RSC advances·2026
Same author

Clinical Outcomes of Stage IIIC Poor-Risk Testicular Germ Cell Tumors: A Retrospective Analysis From a Tertiary Care Center.

Cureus·2026
Same author

Precision Cardio-Oncology and Nuclear Imaging: Current Applications, Molecular Innovations, and Future Trajectories.

Cancers·2026
Same author

Comment on "Effect of Modular Training on Self-Management, Disease, and Treatment Adaptation in Individuals With Hypertension: A Randomized Controlled Trial".

Journal of clinical hypertension (Greenwich, Conn.)·2026

Related Experiment Video

Updated: Jul 7, 2026

Using Multi-fluorinated Bile Acids and In Vivo Magnetic Resonance Imaging to Measure Bile Acid Transport
08:42

Using Multi-fluorinated Bile Acids and In Vivo Magnetic Resonance Imaging to Measure Bile Acid Transport

Published on: November 27, 2016

Amide-functionalized cholic acid hybrids: design, bioactivity, and computational analysis.

Talha Mashhood1, Akbar Ali2,3, Eman Fatima1

  • 1Department of Applied Chemistry, Government College University Faisalabad Faisalabad-38000 Pakistan ibrahim@gcuf.edu.pk.

RSC Advances
|July 6, 2026
PubMed
Summary

Novel cholic acid derivatives show potent antioxidant and selective antibacterial activities. These multifunctional compounds, particularly aromatic amide analogs, offer a promising new framework for developing antimicrobial agents.

More Related Videos

Structure-Guided Design and Development of Novel Cyclophilin A Inhibitors and Ganoderiol-F Derivatives: An In-Silico Approach
10:01

Structure-Guided Design and Development of Novel Cyclophilin A Inhibitors and Ganoderiol-F Derivatives: An In-Silico Approach

Published on: June 23, 2026

Related Experiment Videos

Last Updated: Jul 7, 2026

Using Multi-fluorinated Bile Acids and In Vivo Magnetic Resonance Imaging to Measure Bile Acid Transport
08:42

Using Multi-fluorinated Bile Acids and In Vivo Magnetic Resonance Imaging to Measure Bile Acid Transport

Published on: November 27, 2016

Structure-Guided Design and Development of Novel Cyclophilin A Inhibitors and Ganoderiol-F Derivatives: An In-Silico Approach
10:01

Structure-Guided Design and Development of Novel Cyclophilin A Inhibitors and Ganoderiol-F Derivatives: An In-Silico Approach

Published on: June 23, 2026

Area of Science:

  • Medicinal Chemistry
  • Organic Synthesis
  • Computational Chemistry

Background:

  • Cholic acid derivatives are explored for potential therapeutic applications.
  • Developing multifunctional agents with both antioxidant and antibacterial properties is a key challenge in drug discovery.

Purpose of the Study:

  • To synthesize and characterize novel amide-linked cholic acid derivatives.
  • To evaluate the antioxidant and antibacterial potential of these synthesized compounds.
  • To investigate the molecular interactions underlying their bioactivity using computational methods.

Main Methods:

  • One-pot acyl chloride coupling strategy for synthesis.
  • DPPH radical scavenging assay for antioxidant evaluation.
  • Antibacterial assays against *Staphylococcus aureus* and *Escherichia coli*.
  • In silico studies including molecular docking, molecular dynamics, and MM-PBSA.

Main Results:

  • Structurally diverse cholic acid derivatives were successfully synthesized under mild conditions.
  • Compounds 3b-d demonstrated significant antioxidant activity (average 50% DPPH scavenging).
  • Compounds showed preferential antibacterial activity against Gram-positive bacteria, especially aromatic amide analogs.
  • In silico analyses revealed stable binding modes and favorable energetics against bacterial DNA gyrase (GyrB).

Conclusions:

  • The cholic acid scaffold can be modified to create multifunctional agents.
  • The synthesized derivatives possess promising antioxidant and selective antibacterial properties.
  • These findings provide a solid foundation for developing new antimicrobial drug candidates.